參考文獻/References:
[1] Yoshida K, Toki F, Takeuchi T,et al.Chronic pancreatitis caused by an autoimmune abnormality: Proposal of the concept of autoimmune pancreatitis[J].Digestive Diseases and Sciences, 1995, 40(7): 1561-1568.
[2] 呂紅, 錢家鳴.自身免疫性胰腺炎不同診斷標準的探討[J].胃腸病學, 2009, 14(1): 4.
[3] Okazaki K, Chari S T, Frulloni L,et al.International consensus for the treatment of autoimmune pancreatitis[J].Pancreatology, 2017, 17(1): 1-6.
[4] Ardila-Suarez O, Abril A, Gómez-Puerta J A.Enfermedad relacionada con IgG4: revisión concisa de la literatura[J].Reumatología Clínica, 2017, 13(3): 160-166.
[5] 李德紅,魯彥,張常青,等.IgG4亞類在疑似惡性腫瘤的自身免疫性胰腺炎中的診斷價值[J].國際檢驗醫(yī)學雜志, 2022, 43(1): 126-128.
[6] Sandrasegaran K, Menias C O.Imaging in autoimmune pancreatitis and immunoglobulin G4-related disease of the abdomen[J].Gastroenterology Clinics of North America, 2018, 47(3): 603-619.
[7] 孫備, 冀亮.2016年國際胰腺病學協(xié)會《自身免疫性胰腺炎治療專家共識》解讀[J].中國實用外科雜志, 2017, 37(2): 153-156.
[8] Nagpal S J S, Sharma A, Chari S T.Autoimmune pancreatitis[J].American Journal of Gastroenterology, 2018,113(9):1301.
[9] 張艷蓉, 孟茜茜, 辛磊,等.自身免疫性胰腺炎長期預后的研究進展[J].中華胰腺病雜志, 2022, 22(2): 4.
[10] 丁雪梅, 孫文兵.自身免疫性胰腺炎的診斷和治療[J].中國臨床醫(yī)生雜志, 2010(9): 5.
[11] 高振華, 王軍宏, 萬玉萍,等.自身免疫性胰腺炎臨床治療體會[J].嶺南現(xiàn)代臨床外科, 2021, 21(3): 5.
[12] Tacelli M, Celsa C, Magro B,et al.Risk factors for rate of relapse and effects of steroid maintenance therapy in patients with autoimmune pancreatitis: Systematic review and meta-analysis[J].Clinical Gastroenterology and Hepatology, 2019, 17(6): 1061-1072,e8.